Continuing declines in COVID-19 test revenues was a common theme during the first quarter 2023 earning reports released by the nation’s largest in vitro diagnostics (IVD) manufacturers. At the same time, there was optimism as different IVD firms highlighted advancement and business opportunities in the following areas: • Digital pathology. • Companion diagnostics. • New […]
Despite COVID-19 Losses, IVD Executives Remain Upbeat
Companies report on Q1 2023 financials, looking for growth from expanded molecular testing menus
- By Donna Marie Pocius
- > From the Volume XXX, No. 8 - May 30, 2023 Issue
- Tags: Abbott Laboratories, Alinity, Andre Last, Applied Biosystems QuantStudio Absolute Q Autorun dPCR, assay, BD, Beckman Coulter Diagnostics, Becton, Bernhard Montag, Binding Site, Bio-Rad Laboratories, BioFire SpotFire, bioMerieux, Cepheid, Companion diagnostics, COVID-19, Danaher, Dickinson and Company, digital pathology, Douglas Bryant, DP200, DP600, DRI tramadol assay, Droplet Digital PCR microsatellite instability kit, FDA, Food and Drug Administration, HE600, hematology reagent, Hologic, immunoassay, immunohistochemistry analysis, in vitro diagnostics, IVD, ivd/lab informatics, Karleen Oberton, leica biosystems, Marc Casper, Mark Miller, Matthew Sause, MiniDraw, molecular biology, molecular diagnostics, molecular testing, molecular testing menu, New Mountain Capital, oncology assay, pcr test, PerkinElmer Genomics, PerkinElmer Informatics, point-of-care testing, PTC Temp Thermal Cycler, QuidelOrtho, Rainer Blair, Revvity Omics, Revvity Signals Software, rhinovirus, Robert Ford, roche diagnostics, Roche Group, RSV, SARS-CoV-2, Savana molecular platform, Siemens Healthineers, sysmex, Thermo Fisher Scientific, Tom Polen, urinalysis reagent, Ventana FOLR1 RxDx assay, Xpert Xpress MPV
